Journal of the Formosan Medical Association
Volume 106, Issue 11 , Pages 929-934, November 2007

Major Complications and Associated Risk Factors of Transrectal Ultrasound Guided Prostate Needle Biopsy: A Retrospective Study of 1875 Cases in Taiwan

  • I-Ni Chiang

      Affiliations

    • Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei Branch, Taipei, Taiwan
    • ,
  • Shang-Jen Chang

      Affiliations

    • Department of Urology, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan
    • ,
  • Yeong-Shiau Pu

      Affiliations

    • Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei Branch, Taipei, Taiwan
    • ,
  • Kuo-How Huang

      Affiliations

    • Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei Branch, Taipei, Taiwan
    • ,
  • Hong-Jen Yu

      Affiliations

    • Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei Branch, Taipei, Taiwan
    • ,
  • Chao-Yuan Huang

      Affiliations

    • Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei Branch, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Chao-Yuan Huang, Department of Urology, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan

Received 22 March 2007; received in revised form 26 June 2007; accepted 7 August 2007.

Article Outline

Background/Purpose

Complications from transrectal ultrasound (TRUS) guided prostate needle biopsy are occasionally encountered in the daily practice of urologists. We tried to determine the associated risk factors of patients who suffered from major complications that required hospitalization after TRUS guided prostate needle biopsies.

Methods

We did a retrospective review of 1875 TRUS guided prostate biopsies performed between January 2002 and December 2005. We defined major complications as patients with complications that needed hospitalization. We analyzed the association between biopsy complications and suspected factors, including age, prostate volume, patient's underlying disease, selection of prophylactic antibiotics, biopsy core numbers (6, 12, and 15 cores), and antiplatelet/anticoagulant usage.

Results

There were 124 patients (6.6%) with major complication. These major complications were categorized as acute prostatitis (3.8%), acute urinary retention (2.1%), hematuria (1.9%), rectal bleeding (0.2%), epididymitis (0.2%), sepsis (0.05%), and vasovagal syncope (0.05%). Patients with larger prostate size were noted to have higher risk of developing transient acute prostatitis and acute urinary retention after prostate biopsy. In contrast, age, prophylactic antibiotics (levofloxacin and pipemidic acid), underlying diseases (diabetic mellitus, hypertension, hyperlipidemia, cerebrovascular accident, coronary artery disease), increased biopsy core numbers, and antiplatelet/anticoagulant usage were not associated with major complications after prostate biopsy.

Conclusion

TRUS guided prostate needle biopsy is a safe diagnostic tool in most elderly males with or without systemic underlying disease.

Key Words:  complications , morbidity , risk factors , transrectal ultrasound prostate needle biopsy , TRUS

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Fitzsimons NJ , Sun L , Moul JW . Medical technologies for the diagnosis of prostate cancer . Expert Rev Med Devices . 2007;4:227–239
  2. Berger AP , Gozzi C , Steiner H , et al.   Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores . J Urol . 2004;171:1478–1480
  3. Djavan B , Waldert M , Zlotta A , et al.   Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study . J Urol . 2001;166:856–860
  4. Chang CK , Yu HJ , Chan KW , Lai MK . Secular trend and age-period-cohort analysis of prostate cancer mortality in Taiwan . J Urol . 1997;158:1845–1848
  5. Raaijmakers R , Kirkels WJ , Roobol MJ , et al.   Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program . Urology . 2002;60:826–830
  6. Sech S , Montoya J , Girman CJ , et al.   Interexaminer reliability of transrectal ultrasound for estimating prostate volume . J Urol . 2001;166:125–129
  7. Taylor HM , Bingham JB . The use of prophylactic antibiotics in ultrasound-guided transrectal prostate biopsy . Clin Radiol . 1997;52:787–790
  8. Larsson P , Norming U , Tornblom M , Gustafsson O . Antibiotic prophylaxis for prostate biopsy: benefits and costs . Prostate Cancer Prostatic Dis . 1999;2:88–90
  9. Puig J , Darnell A , Bermudez P , et al.   Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary? . Eur Radiol . 2006;16:939–943
  10. Sabbagh R , McCormack M , Peloquin F , et al.   A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy . Can J Urol . 2004;11:2216–2219
  11. Tobias-Machado M , Correa TD , De Barros EL , Wroclawski ER . Antibiotic prophylaxis in prostate biopsy. A comparative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol . Int Braz J Urol . 2003;29:313–319
  12. Yang L , Hu J , Wei H , et al.   Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy . Zhonghua Wai Ke Za Zhi . 2001;39:940–942 [In Chinese]
  13. Enlund AL , Varenhorst E . Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases . Br J Urol . 1997;79:777–780
  14. Griffith BC , Morey AF , Li-Khan MM , et al.   Single dose levo-floxacin prophylaxis for prostate biopsy in patients at low risk . J Urol . 2002;168:1021–1023
  15. Lindert KA , Kabalin JN , Terris MK . Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy . J Urol . 2000;164:76–80

PII: S0929-6646(08)60063-7

doi:10.1016/S0929-6646(08)60063-7

Journal of the Formosan Medical Association
Volume 106, Issue 11 , Pages 929-934, November 2007

Article Tools